Douglas Clyde Brey, LLP | |
220 Washington Ave, Oshkosh, WI 54901-5030 | |
(920) 236-4700 | |
(920) 236-1157 |
Full Name | Douglas Clyde Brey |
---|---|
Gender | Male |
Speciality | Counselor - Professional |
Location | 220 Washington Ave, Oshkosh, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093886723 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TB0200X | Psychologist - Cognitive & Behavioral | 6301011664 (Michigan) | Secondary |
101YP2500X | Counselor - Professional | 4871 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Douglas Clyde Brey, LLP 220 Washington Ave, Oshkosh, WI 54901-5030 Ph: (920) 236-4700 | Douglas Clyde Brey, LLP 220 Washington Ave, Oshkosh, WI 54901-5030 Ph: (920) 236-4700 |
News Archive
A single dose of cocaine can interfere with the ability to recognise negative emotions, according to new research presented at the ECNP conference in Amsterdam.
Global Net Access (GNAX), a leading healthcare technology infrastructure service provider unveils a new Free Health Information Exchange (HIE) today at the 2011 Annual HIMSS Conference & Exhibition. The GNAX HIE facilitates the direct electronic exchange of patient information between healthcare providers.
Researchers say these findings highlight the need for improved diagnosis and treatment of sleep disorders in mild traumatic brain injury patients who complain of insomnia.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. "To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design", says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.
› Verified 7 days ago